SONM
DNA X, Inc.
NASDAQ · Technology · Communication Equipment · US
$3.24
+0.68%Aug 19, 2026, 20:15 UTC
DNA X, Inc. raised $1.8 million in cash from new convertible debt during the second quarter of 2026.
Source:Aug 19, 2026, 20:15 UTC
DNA X, Inc. raised $5.0 million through the sale of preferred stock after the end of the second quarter of 2026.
Source:Aug 8, 2026, 13:03 UTC
Meta Platforms is paying neo-Nazi and white supremacist content creators through its Facebook Content Monetization program, as revealed by an ABC News investigation.
Source:Jul 13, 2026, 18:00 UTC
Meta Platforms Inc filed a legal challenge in the High Court against Coimisiún na Meán's decision to open investigations into alleged infringements of the EU Digital Services Act regarding recommender feeds on Facebook and Instagram.
Source:Jul 9, 2026, 00:00 UTC
DNA X, Inc. completed a private placement of unregistered Series B Preferred Stock, raising $2.5 million in cash and cancelling $3.1 million of debt principal, with 416,667 subscribed shares still to be issued by August 14, 2026.
Jul 2, 2026, 00:00 UTC
DNA X, Inc. agreed to issue and sell 1,346,531 shares of non-voting Series B Convertible Preferred Stock to DNA Holdings Venture, Inc. for an aggregate purchase price of approximately $8.1 million.
May 27, 2026, 00:00 UTC
DNA X, Inc. entered into a securities purchase agreement on May 26, 2026, issuing a convertible promissory note to DNA Holdings Venture, Inc. for total proceeds of $3,052,787.68, consisting of $1,800,000 cash and the surrender of a bridge note with accrued interest, convertible at $6.00 per share.